English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Bioblast Pharma
+
Technology/Innovation
Jamie Barrand
| Dec 12, 2015
BioBlast researchers develop new therapies for oculopharyngeal muscular dystrophy
Trending
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Regulatory
M. Y. Bailey
| Aug 7, 2026
PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports
| Aug 10, 2026
SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
